Amy Sullivan - 23 Dec 2024 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role: Chief Financial Officer
Signature: /s/ Brian Burkavage, Attorney-in-Fact for Amy Sullivan
Issuer symbol: IOBT
Transactions as of: 23 Dec 2024
Net transactions value: +$8,483
Form type: 4
Filing time: 23 Dec 2024, 18:53:56 UTC
Previous filing: 18 Mar 2024
Next filing: 04 Apr 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IOBT	Common Stock	Purchase	$8,483	+10,250	+14%	$0.8276	84,632	23 Dec 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transaction was executed in multiple trades in prices ranging from $0.7861 to $0.90, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The transaction was executed in multiple trades in prices ranging from $0.7861 to $0.90, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.